Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial

Publisher： Karger

E-ISSN： 1421-9751|137|4|207-217

ISSN： 0008-6312

Source： Cardiology, Vol.137, Iss.4, 2017-04, pp. : 207-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical outcome of patients with implantation of second‐generation drug‐eluting stents in the right coronary ostium: Insights from 2‐year follow‐up of the TWENTE trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 524-531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improving Outcomes in High-Risk Percutaneous Coronary Interventions and Newer-Generation Drug-Eluting Stents: Good, But Not Good Enough

By  

Cardiology, Vol. 138, Iss. 2, 2017-06 ,pp. : 73-75

Karger

Access to resources Recommend Favorite

Distal Left Main Coronary Bifurcation Lesions Predict Worse Outcome in Patients Undergoing Percutaneous Implantation of Drug-Eluting Stents: Results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study

By  

Cardiology, Vol. 113, Iss. 4, 2009-02 ,pp. : 264-273

Karger

Access to resources Recommend Favorite

A 10‐month angiographic and 4‐year clinical outcome of everolimus‐eluting versus sirolimus‐eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial)

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 7, 2015-12 ,pp. : 1161-1167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical outcome of DES versus BMS

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 2, 2015-02 ,pp. : 203-211

John Wiley & Sons Inc

Access to resources Recommend Favorite